Infinimmune Inc. raised $75 million in a series A round, co-led by Regeneron Ventures and Playground Global, to advance its IL-22-targeted IFX-101 and IL-13-targeted IFX-201 into the clinic in 2027 ...
The scientific community continues to make progress at uncovering the elements that could lead to a cure for HIV. The virus ...
Accutar Biotechnology Inc. has reported proteolysis targeting chimera (PROTAC) compounds comprising an E3 ubiquitin-protein ligase binding moiety covalently bound to kinesin-like protein KIF11 (KSP; ...
Citing structural synergies and a diversified portfolio, Supernus Pharmaceuticals Inc. and Indivior Pharmaceuticals Inc. are combining operations in a tax-free, all-stock merger. Upon close of the ...
Bad news from the Novo Nordisk A/S phase III trial called Zeus with IL-6 inhibitor ziltivekimab struck a blow to some drug developers’ theory about heart disease – and to their stocks. An update on ...
A Senate Finance subcommittee held a brainstorming session of sorts to explore ways to spur U.S. innovation to address two of the biggest threats to growing a strong domestic biotech sector. Those ...
After capturing the North American market with Wegovy (semaglutide) and Zepbound (tirzepatide), Novo Nordisk A/S and Eli Lilly and Co. are advancing blockbuster glucagon-like peptide-1 (GLP-1) ...
In what the U.S. Department of Justice is calling the “largest Sunshine Act recovery in history,” Veloxis Pharmaceuticals Inc. agreed to pay CMS a $1.55 million civil penalty to resolve allegations ...
Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.
Infinimmune Inc. raised $75 million in a series A round, co-led by Regeneron Ventures and Playground Global, to advance its IL-22-targeted IFX-101 and ...
New hires and promotions in the biopharma and med-tech industries in Asia-Pacific, including: Ascentage.
Clinical updates for biopharma and med tech in Asia-Pacific, including data readouts and publications: Clarity, Huidagene, Micot, Otsuka.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results